Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2000
12/26/2000US6165794 Suppression of proteolytic activity by dysfunctional protease formation
12/26/2000US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents
12/26/2000US6165790 Antisense modulation of PI3 kinase p55 gamma expression
12/26/2000US6165788 Antisense modulation of Survivin expression
12/26/2000US6165787 Regulated transcription of targeted genes and other biological events
12/26/2000US6165782 Nucleotide sequences for the transfer of heterologous nucleotide sequences to cells and biosynthesis of transcripts and heterologous proteins
12/26/2000US6165781 Nucleotide sequences comprising an inverted terminal duplication and heterologous nucleotide sequences; for the treatment of genetic disorders and gene therapy
12/26/2000US6165779 Recombinant virus vector such as tumor suppressor gene formulated in a buffer comprising a detergent; for gene therapy of cancer; buffer comprising a delivery-enhancing agent
12/26/2000US6165771 Compounds
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165764 Polynucleotides encoding tRNA methyl transferases from Streptococcus pneumoniae
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165754 Method of expressing an exogenous nucleic acid
12/26/2000US6165753 Cyclin E genes and proteins
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165720 Conjugating nucleic acid with a peptide nucleic acid in a sequence-specific manner prior to transfection, transfecting cell with conjugate, and monitoring intracellular location
12/26/2000US6165719 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
12/26/2000US6165712 Contacting a cell with an exogenous molecule effective to modulate gene expression and affect level of protein thus pathological effect; molecule binds to regulatory sequence, rna, or transcription regulating protein; viricides
12/26/2000US6165462 Sugar kinase
12/26/2000US6165460 Generation of immune responses to prostate-specific antigen (PSA)
12/26/2000US6165440 Radiation and nanoparticles for enhancement of drug delivery in solid tumors
12/21/2000WO2000077262A1 Synthetic ligation reassembly in directed evolution
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077252A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000WO2000077232A1 Promoters from atlantic salmon
12/21/2000WO2000077227A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000WO2000077210A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077195A1 Nucleic acid encoding novel egf-like growth factors
12/21/2000WO2000077192A1 Reg-binding protein
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000WO2000077188A2 Dna pcv vaccine
12/21/2000WO2000077177A2 Isolation of a human retrovirus
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077168A2 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS
12/21/2000WO2000077167A2 Herpes simplex virus amplicon vector targeting system and method of using same
12/21/2000WO2000077166A2 Gene expression modulated in gastrointestinal inflammation
12/21/2000WO2000077044A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/21/2000WO2000077043A2 Dna vaccines for pets and sport animals
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077038A2 P202 is a tumor suppressor
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077032A2 Spermine:peptide-based surfactant compounds
12/21/2000WO2000077026A1 49 human secreted proteins
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076554A1 Ligand-conjugated oligomeric compounds
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076552A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000WO2000076542A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000WO2000076541A1 Pneumococcal surface protein combination vaccine
12/21/2000WO2000076540A2 Streptococcus pneumoniae proteins and vaccines
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000052187A3 Enhanced system for construction of adenovirus vectors
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000050008A3 Antibody fragment-targeted immunoliposomes for systemic gene delivery
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/21/2000CA2392514A1 Reg-binding protein
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2383041A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2379327A1 Pneumococcal surface protein combination vaccine
12/21/2000CA2378745A1 Ligand-conjugated oligomeric compounds
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 870